CPQuali Pesquisa Clínica
CPQuali Pesquisa Clínica
Avenida Angélica, 916 Conjunto 506 - São Paulo 01228-000
Select an option
I am a doctor
I am a sponsor
Our team
Medical staff
Caroline Pane
Rayssa Ortiz Firmino do Amaral
Gustavo Akerman Augusto
Gabriel Rosario
Myrella Machado
Augusto Santomauro Junior
Camila Leanca Canteiro
Leonel Takada
Thalyta Lopes
Rafaela Santos Martins
Gustavo Augusto
Mariane Alves Escudeiro
Vitoria Nelo
Gustavo Fagundes
Karina Pedroti Forlenza
Rafael Paterno Castello Dias Carneiro
Pedro Kurita
João Paulo Teixeira Leite Ramos
Maria Tereza Martinez
Renata Canovas
Luiza Villarim
Carolina Perniquelli
Moacyr Alexandre Rosa
Luciana Anzei
Ingrid Silva
Mauricio Sa Oliveira
Natali Maia
Giovanna Milinkovic
Marcelo Cardoso
Elizangela Fernandes Nogueira
Fabiola Franco Godoi
Rafaela Ribas
Maria Elisangela de Sousa
Monica Daniel Souza
Rosemar Joaquim da Silva
Barbara Silveira
Julia Silveira
Diogo Haddad Santos
Flavia Timbo Albuquerque
Mariana Correa de Souza
Vitoria Giovanna Sampaio
Milena Failla Preti
Ana Laura Carneiro Parizi
Maryane Sena
Rafael Paterno Castello Dias Carneiro
Camila Regina de Macedo
Luciana Seoane
Rafaela Freitas
Felipe Nogueira
Kyara Freire
Luciana Cristina da Silva
Mariana Fernandes
Thiago Reis
Monica Neves
Flavia Logatti
Carolina Guilhen
Patricia Helena Zanoni
Maria Tereza Martinez U
Open studies
Cardiovascular disease
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity - MARITIME-CV - AmgenSee more
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) - MOVE-Lp(a) - Eli Lilly and CompanySee more
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes) - ATTAIN-Outcomes - Eli Lilly and CompanySee more
Alzheimer disease
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4) - ADEPT-4 - Karuna TherapeuticsSee more
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1) - ADAGIO 1 - Bristol-Myers SquibbSee more
Schizophrenia
Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-2) - CONNEX-1 CONNEX-2 CONNEX-3 - Boehringer IngelheimSee more
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder - ENLIGHTEN-Youth - Alkermes, Inc.See more
Obesity
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity - MARITIME-CV - AmgenSee more
Bipolar disorder
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder - ENLIGHTEN-Youth - Alkermes, Inc.See more
Elevated Lipoprotein A
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) - MOVE-Lp(a) - Eli Lilly and CompanySee more
Renal disease
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes) - ATTAIN-Outcomes - Eli Lilly and CompanySee more
